Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Neuroendocrine Tumors 1Liver Neoplasms 1Liver Abscess 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Adenoma 1

Interventions

Sorafenib 22Bevacizumab 15pembrolizumab 10durvalumab 7Nivolumab 7Ipilimumab 6Drug Therapy 6atezolizumab 5Talaporfin 5spartalizumab 4regorafenib 4lenvatinib 4derazantinib 3Ramucirumab 3Photochemotherapy 3Leucovorin 3Injections 3Fluorouracil 3Doxorubicin 3tremelimumab 2toripalimab 2seocalcitol 2relatlimab 2phosphomannopentaose sulfate 2liposomal doxorubicin 2exatecan 2cabozantinib 2brivanib 2Phototherapy 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Liver Neoplasms × gadolinium ethoxybenzyl DTPA × Clear all
NCT01043523 2016-11-28

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Bayer

Completed
52 enrolled 27 charts
Gastrointestinal

Adenoma, Carcinoma, Carcinoma, Hepatocellular, Liver Abscess, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡